Cash Flow Statement

Cellectis (CLLS) Total Current Liabilities (2016 - 2025)

Cellectis has reported Total Current Liabilities over the past 12 years, most recently at $145.8 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $145.8 million for Q4 2025, down 12.34% from a year ago — trailing twelve months through Dec 2025 was $145.8 million (down 12.34% YoY), and the annual figure for FY2025 was $145.8 million, down 12.34%.
  • Total Current Liabilities for Q4 2025 was $145.8 million at Cellectis, down from $166.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for CLLS hit a ceiling of $166.3 million in Q4 2024 and a floor of $42.0 million in Q2 2023.
  • Median Total Current Liabilities over the past 5 years was $49.3 million (2021), compared with a mean of $92.9 million.
  • Biggest five-year swings in Total Current Liabilities: skyrocketed 222.34% in 2023 and later decreased 12.34% in 2025.
  • Cellectis' Total Current Liabilities stood at $49.3 million in 2021, then decreased by 2.47% to $48.1 million in 2022, then skyrocketed by 222.34% to $155.1 million in 2023, then increased by 7.17% to $166.3 million in 2024, then fell by 12.34% to $145.8 million in 2025.
  • The last three reported values for Total Current Liabilities were $145.8 million (Q4 2025), $166.3 million (Q4 2024), and $155.1 million (Q4 2023) per Business Quant data.